Clinical Trials

LymphoidMyeloidOther hematologic neoplasm

36 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03737695 2026-03-18

Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer

300 enrolled

Breast Neoplasms

NCT04301076 2026-03-18

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

LymphoidOther hematologic neoplasm

Lymphoma, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04616560 2026-03-18

Trastuzumab Deruxtecan for the Treatment of HER2+ Newly Diagnosed or Recurrent Osteosarcoma

77 enrolled

Sarcoma

Osteosarcoma

NCT04799275 2026-03-18

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

422 enrolled

Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone

NCT04840589 2026-03-18

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

66 enrolled

Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms

NCT04929041 2026-03-18

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

427 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04955808 2026-03-18

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

BreastGastrointestinalGenitourinaryPlasma cell

2,400 enrolled

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Carcinoma, Hepatocellular, Multiple Myeloma, Prostatic Neoplasms

NCT05223036 2026-03-18

Testing Obeticholic Acid for Familial Adenomatous Polyposis

80 enrolled

Attenuated familial adenomatous polyposis, Duodenal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT05372614 2026-03-18

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

33 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT05432804 2026-03-18

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

97 enrolled

Glioblastoma

NCT05554380 2026-03-18

Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

33 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT05642195 2026-03-18

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

NCT06015880 2026-03-18

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Lymphoma, Large B-Cell, Diffuse

NCT06732401 2026-03-18

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

630 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06802523 2026-03-18

Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia

Other hematologic neoplasm

53 enrolled

Leukemia, Myeloid, Acute

NCT06888323 2026-03-18

Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment

Myeloid

Myelodysplastic Syndromes

NCT07283705 2026-03-18

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

60 enrolled

Phase 2 Study

NCT05111561 2026-03-17

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

42 enrolled

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT05656131 2026-03-17

Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer

80 enrolled

Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer

NCT07039630 2026-03-17

A Food Security Intervention for the Prevention of Cancer in Low-income Families

50 enrolled

OtherOther neoplasm

Obesity-Related Malignant Neoplasm

NCT06626633 2026-03-12

2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML

Other hematologic neoplasm

6 enrolled

Leukemia, Myeloid, Acute

NCT07011550 2026-03-11

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

7 enrolled

Microsatellite-stable Colorectal Cancer

NCT06963346 2026-03-09

Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents

12 enrolled

Urinary Bladder Neoplasms

NCT05597878 2026-03-06

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

100 enrolled

Agnosia, Prostatic Neoplasms

NCT06219174 2026-03-06

Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)

45 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06281925 2026-03-06

Cryotherapy & Oxaliplatin

40 enrolled

Colonic Neoplasms, Peripheral Nervous System Diseases

NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

126 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06860386 2026-03-06

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

75 enrolled

Carcinoma, Renal Cell

NCT03077841 2026-03-05

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

928 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06934928 2026-03-05

Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)

10 enrolled

Neurofibromatosis 1, Neurofibromatoses

NCT07136493 2026-03-05

Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer

350 enrolled

Triple Negative Breast Neoplasms

NCT03994796 2026-03-04

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

186 enrolled

Brain Neoplasms, Neoplasm Metastasis

NCT05842031 2026-03-04

Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer

20 enrolled

Penile Neoplasms

NCT05904899 2026-03-04

An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Management of Cancer Patients

40 enrolled

Tumor-Agnostic

Neoplasms

NCT05960773 2026-03-04

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

Other solid neoplasmThoracic

9 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT06159790 2026-03-04

A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)

218 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06232044 2026-03-04

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma

88 enrolled

Plasma cell

Multiple Myeloma

NCT06671912 2026-03-04

LoTam

1,156 enrolled

Breast Carcinoma In Situ

NCT05050162 2026-03-03

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

1,714 enrolled

Head & Neck

Carcinoma, Oropharyngeal Neoplasms

NCT03150693 2026-03-02

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

310 enrolled

Burkitt Lymphoma

NCT06085729 2026-02-27

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

Phase EARLY_PHASE1 Suspended

Prostatic Neoplasms

NCT06235281 2026-02-27

PLIGHT

20 enrolled

Mycosis Fungoides

NCT05419479 2026-02-24

Switch Maintenance in Pancreatic

46 enrolled

Pancreatic Neoplasms

NCT07025538 2026-02-23

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

42 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07224503 2026-02-23

C-SMART vs BE Well for Patients With Brain Tumors

42 enrolled

Brain Neoplasms

NCT05028621 2026-02-20

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

135 enrolled

LymphoidMyeloid

Castleman Disease, Histiocytosis, Langerhans-Cell, Histiocytosis, Non-Langerhans-Cell

NCT02993068 2026-02-19

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

5,200 enrolled

Triple Negative Breast Neoplasms

NCT05403723 2026-02-19

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

50 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT06909201 2026-02-19

Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity

70 enrolled